# What Changes in Neurology Coding and Billing in 2027?

> Neurology coding changes for 2027 cover new autonomic and sleep testing codes, the proposed Medicare fee cut, the G2211 overhaul and the denials to watch.

Source: https://webillhealth.com/key-neurology-coding-changes-every-physician-should-know/  
Publisher: WeBill Health  
Last updated: November 2, 2026

For independent neurology practices, the biggest 2027 coding changes sit in autonomic function testing and unattended sleep testing, both rebuilt in CPT 2027 for dates of service on and after January 1, 2027. Medicare payment is also moving. CMS proposed a 1.68% cut to the conversion factor for most clinicians and a new modifier to replace G2211. Routine EEG and nerve conduction codes show no highlighted CPT changes this cycle, so the main work there is defending claims you already bill.

## What did the AMA release for CPT 2027?

The AMA released the CPT 2027 code set on September 9, 2026. It contains 299 new codes, 74 revised codes and 80 deletions, for 453 editorial changes in total. The codes take effect January 1, 2027.

The AMA press release named a handful of headline areas. Sleep medicine was one of them, with six new codes for unattended sleep studies. Biofeedback moves to a new time based structure, which matters if your practice offers biofeedback for headache care. The release did not mention EEG, nerve conduction studies or office E/M visits.

For a broader view of what changes outside neurology, see our guide to [CPT 2027 code changes for small practices](https://webillhealth.com/cpt-2027-code-changes-small-practices/).

## Which neurology code families change in CPT 2027?

The table below sums up the neurology families and what we could verify for each one.

| Code family | CPT 2027 status | What to do before January 1 |
|---|---|---|
| Unattended sleep testing (95800, 95801, 95806) | Deleted and replaced by six new codes | Update charge masters, order forms and payer fee loads |
| Autonomic function testing (95921 to 95924) | Four codes revised, new codes added | Retrain on which test goes with which code |
| Biofeedback | New time based structure | Document start and stop times |
| EEG and long term EEG monitoring | No changes named by the AMA or listed in the CMS proposed rule headings | Confirm in the 2027 codebook |
| Nerve conduction and needle EMG (95885 to 95913) | No changes named by the AMA or listed in the CMS proposed rule headings | Focus on medical necessity and unit limits |

The EEG and nerve conduction rows rest on the AMA release and the code list in the CMS proposed rule. Check the published 2027 codebook before treating them as final.

## How are unattended sleep testing codes changing?

The CPT Editorial Panel deleted 95800, 95801 and 95806, the home sleep apnea test codes many neurology practices with a sleep program bill today. Six new codes replace them on January 1, 2027. The CMS proposed rule refers to them by the placeholders 95X18 to 95X23. Final numbers and full descriptors appear in the 2027 CPT codebook and the September 2026 issue of CPT Assistant.

Payment under the new set follows the complexity of the data collected, in low, moderate and high tiers, and no longer depends on device type. CMS proposed the RUC recommended values for five of the six codes. For the sixth, 95X23, CMS proposed a work RVU of 1.42 against the RUC recommendation of 1.60. The American Academy of Sleep Medicine has opposed that reduction.

Set one internal rule for tests that start in December and are read in January, and apply it every time.

## What changes in autonomic function testing?

CPT 2027 splits the old autonomic testing codes into more specific services. Per the AAPC Neurology Coding Alert, the four existing codes (95921, 95922, 95923, 95924) now include “interpretation and report” in their descriptors, and 95922 and 95924 state tilt table testing directly.

New codes cover tests that used to sit inside 95923 or were reported in combination. AAPC lists them as follows.

| New code | Service |
|---|---|
| +95944 | Tilt table add on, reported only with 95921 or 95947 |
| 95945 | Thermoregulatory sweat test |
| 95946 | Sympathetic skin response |
| 95947 | Combined parasympathetic and sudomotor testing |
| 95948 | Combined sympathetic adrenergic (with tilt table) and sudomotor testing |
| 95949 | Combined parasympathetic, sympathetic adrenergic (with tilt table) and sudomotor testing |

QSART and silastic sweat imprint stay under 95923. Thermoregulatory sweat testing moves to 95945, and sympathetic skin response moves to 95946. The CMS proposed rule lists this family for valuation under placeholder numbers, which confirms the restructure is on track for 2027.

If you run an autonomic lab, check each payer’s 2027 fee schedule. Commercial payers often load new codes late, and correct claims can deny as invalid in January.

## Did ICD 10 CM FY2027 change neurology diagnosis codes?

Very little. The FY2027 ICD 10 CM update took effect October 1, 2026, for encounters through September 30, 2027. We reviewed the CMS tabular addendum. Chapter 6, Diseases of the nervous system (G00 to G99), has no new codes this year. The only Chapter 6 entry adds “Midline shift of brain” as an inclusion term under G93.5, Compression of brain.

Two nearby changes matter for neurology coders. The “code first” note under F02, Dementia in other diseases classified elsewhere, now points frontotemporal neurocognitive disorder to G31.09. The note under R29.7, the NIH Stroke Scale score, now tells coders to sequence the type of stroke first across I60, I61, I62 and I63, where it previously listed only cerebral infarction (I63).

The update also adds Z77.40 to Z77.49 for contact with and suspected exposure to blast overpressure, which may apply in head injury evaluations for veterans and service members. There are no new migraine (G43), epilepsy (G40) or Parkinson disease (G20) codes for FY2027.

## What is in the CY2027 Medicare physician fee schedule?

CMS released the CY2027 physician fee schedule proposed rule on July 14, 2026, and comments closed September 14, 2026. As of October 29, 2026, the final rule has not been published. The American Academy of Sleep Medicine expected it in late October or early November.

These proposals touch neurology most.

| Proposal | Detail |
|---|---|
| Conversion factor | $32.8409 for clinicians who are not qualifying APM participants, a 1.68% cut. $33.1693 for qualifying APM participants, a 1.19% cut |
| G2211 | Replaced by a modifier (placeholder MOD1) on the E/M code that raises its payment 16%. A second modifier (MOD2) for Shared Savings Program and LEAD Model ACO participants raises it 32% |
| Same day E/M and procedure | When a separately identifiable office E/M is billed on the same day as a 0, 10 or 90 day global procedure by the same physician or group, the higher valued service is paid at 100% and the other at 50% |
| Remote monitoring | RTM limited to established patients, a separately reportable initiating visit required, and payment only for services furnished by clinical staff the practice employs |

The cut comes mostly from the expiring one year 2.50% increase for 2026. For a model of what it does to a small group, see [what the CY2027 fee schedule cut means for a 3 to 5 provider practice](https://webillhealth.com/what-the-cy2027-fee-schedule-cut-means-for-a-3-to-5-provider-practice/).

The G2211 change matters for neurology because so much of the work is longitudinal. Patients with epilepsy, multiple sclerosis, Parkinson disease or dementia often see the same neurologist for years. If finalized, charge entry moves from an add on code to a modifier on January 1.

The same day reduction affects neurologists who inject on the day of a visit, such as nerve blocks and trigger point injections. Check each procedure’s global period in the fee schedule. Our breakdown of the [modifier 25 payment cut for 2027](https://webillhealth.com/cms-modifier-25-payment-cut-2027/) walks through the math.

Per the AMA summary, Medicare telehealth flexibilities, including home based visits, run through 2027 under the Consolidated Appropriations Act, 2026.

## Which neurology claims get denied most often?

### E/M level downcoding

Payers continue to reduce high level office visits when the note does not support the medical decision making or total time billed. A clear assessment and plan for each problem, with the data reviewed and the risk of management, gives a reviewer what they need. We track the payer side of this in our report on [the national downcoding trend](https://webillhealth.com/insurance-claim-downcoding-2026-national-payer-trend/).

### Prolonged services

Medicare does not use CPT 99417. It uses G2212 for prolonged office time. First Coast Service Options lists the Medicare thresholds as 69 minutes of total time on the date of service before one unit of G2212 can be added to 99215, and 89 minutes before one unit can be added to 99205. Each further unit needs another full 15 minutes. Billing 99417 to Medicare, or adding G2212 at the CPT threshold, produces avoidable denials. Commercial plans often accept 99417, so map the code by payer.

### Nerve conduction and EMG frequency

CMS approved Recovery Audit issue 0187, Nerve Conduction Studies: Excessive Units, which covers 95905 and 95907 to 95913 and lists the NCS and EMG LCDs of every A/B MAC.

The rules differ by MAC. The Novitas LCD (L35081) allows two studies per 12 months per diagnosis per provider for carpal tunnel, radiculopathy, mononeuropathy, polyneuropathy, myopathy and neuromuscular junction disorders, and three for motor neuron disease and plexopathy. It also includes a maximum number of studies table by indication. Radiculopathy, for example, allows 2 needle EMG studies, 3 motor NCS, 2 sensory NCS and 2 H reflex studies. The Wellpoint Federal (formerly NGS) LCD (L35098) sets no numeric yearly limit. It requires the pre test history and exam to document the need for the test and states that a rule out diagnosis is typically not acceptable.

Count units against your MAC’s table before the claim goes out, and document the reason for any repeat study inside 12 months.

### Botox for chronic migraine

OnabotulinumtoxinA claims fail on diagnosis criteria, dosing interval and missing authorization. Medicare requires prior authorization for botulinum toxin injections in hospital outpatient departments, a program that started July 1, 2020. The CMS program page addresses hospital outpatient departments only.

Commercial plans set their own rules. One example is the UnitedHealthcare Individual Exchange policy effective January 1, 2026, which requires at least 15 headache days per month, at least 8 migraine days per month and headaches lasting 4 or more hours a day. It also limits injections to no more often than every 12 weeks.

Medicare coverage criteria are also under review. In 2026, several MACs released a proposed Botulinum Toxin Injections LCD (DL39857 at one contractor), and the American Academy of Neurology filed comment letters on May 8, 2026. The AAN asked the MACs to accept failure of one preventive agent, to add CGRP agents to the list of qualifying prior treatments, and to drop mandatory objective clinical scales. Watch for the final LCD from your MAC before your 2027 injection schedule fills up. Our guide to [prior authorization changes in 2027](https://webillhealth.com/prior-authorization-changes-2027/) covers the payer side.

## How WeBill Health handles neurology coding changes for 2027

WeBill Health maintains internal payer rule libraries organized by specialty and by carrier, built and updated by experts who work claims in your specialty every day. Every claim receives human pre submission review against them before it goes out, across more than 500 payer rulesets. For neurology, the libraries include MAC electrodiagnostic tables, botulinum toxin criteria and each payer’s prolonged service code.

Before January 1, 2027, our team loads the new sleep and autonomic codes, retires 95800, 95801 and 95806, and checks each payer’s fee schedule for the new codes. Denials are prevented at the source and, when they happen, worked at the root cause so the same error does not repeat. Practices partnering with WeBill Health see a 98% clean claim rate and a 48 hour submission guarantee, with tools for seamless communication with our team.

**Is your neurology practice ready for January 1?** [Request your Revenue Defense Audit](https://webillhealth.com/form/) and we will review your E/M levels, electrodiagnostic unit counts, prolonged service coding and Botox authorization workflow. For a quick read first, [get your Revenue Defense Score](https://webillhealth.com/revenue-defense-score/) in 60 seconds.

## Frequently asked questions

### When do the 2027 neurology CPT codes take effect?

The CPT 2027 code set takes effect for dates of service on and after January 1, 2027. Codes deleted in CPT 2027, such as 95800, 95801 and 95806, should not be billed for services performed on or after that date.

### Are there new EEG or nerve conduction codes in 2027?

We found none. The AMA release does not mention EEG or nerve conduction changes, and the code list in the CMS proposed rule does not include those families. Confirm against the 2027 CPT codebook.

### Is the 2027 Medicare conversion factor final?

No. As of October 29, 2026, CMS had published only the proposed rule, with a conversion factor of $32.8409 for clinicians who are not qualifying APM participants. The final rule is expected in late October or early November 2026.

### Were any new ICD 10 CM neurology codes added for FY2027?

No new codes were added to Chapter 6 (G00 to G99). The FY2027 changes near neurology are an inclusion term under G93.5, revised notes under F02 and R29.7, and new blast overpressure exposure codes Z77.40 to Z77.49.

## Sources

1. [AMA releases CPT 2027 code set](https://www.ama-assn.org/press-center/ama-press-releases/ama-releases-cpt-2027-code-set)
2. [AASM, New unattended sleep testing CPT codes and the CMS proposed rule](https://aasm.org/new-unattended-sleep-testing-cpt-codes-cms-proposed-rule/)
3. [AASM, Support fair payment of the new unattended sleep testing codes](https://aasm.org/support-fair-payment-of-the-new-unattended-sleep-testing-codes/)
4. [AASM, Get an early look at the new unattended sleep testing CPT codes](https://aasm.org/get-an-early-look-at-the-new-unattended-sleep-testing-cpt-codes/)
5. [Managed Healthcare Executive, Home sleep apnea testing faces payment cut](https://www.managedhealthcareexecutive.com/view/home-sleep-apnea-testing-faces-payment-cut)
6. [AAPC Neurology Coding Alert, Nervous system function test codes get major overhaul in CPT 2027](https://www.aapc.com/codes/coding-newsletters/my-neurology-coding-alert/neurology-pain-management-coding-nerve-system-function-test-codes-get-major-overhaul-in-cpt-2027-180733-article)
7. [Federal Register, CY 2027 Payment Policies Under the Physician Fee Schedule (proposed rule)](https://www.federalregister.gov/documents/2026/07/16/2026-14327/medicare-and-medicaid-programs-cy-2027-payment-policies-under-the-physician-fee-schedule-and-other)
8. [CMS fact sheet, CY 2027 Medicare Physician Fee Schedule proposed rule](https://www.cms.gov/newsroom/fact-sheets/calendar-year-cy-2027-medicare-physician-fee-schedule-proposed-rule)
9. [AMA summary of the 2027 MPFS proposed rule](https://www.ama-assn.org/system/files/ama-2027-mpfs-proposed-rule-summary.pdf)
10. [AHA, CMS issues CY 2027 physician fee schedule proposed rule](https://www.aha.org/news/headline/2026-07-14-cms-issues-cy-2027-physician-fee-schedule-proposed-rule)
11. [CMS, ICD 10 codes and FY2027 addendum](https://www.cms.gov/medicare/coding-billing/icd-10-codes)
12. [First Coast Service Options, Prolonged physician services in office and other outpatient visits](https://medicare.fcso.com/evaluation-and-management/prolonged-physician-services-office-and-other-outpatient-visits)
13. [CMS, RAC issue 0187, Nerve Conduction Studies: Excessive Units](https://www.cms.gov/research-statistics-data-and-systems/monitoring-programs/medicare-ffs-compliance-programs/recovery/1146164386/0187-nerve-conduction-studies-excessive-units)
14. [Novitas LCD L35081, Nerve Conduction Studies and Electromyography](https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?LCDId=35081)
15. [Wellpoint Federal LCD L35098, Nerve Conduction Studies and Electromyography](https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?LCDId=35098)
16. [CMS, Prior authorization for certain hospital outpatient department services](https://www.cms.gov/data-research/monitoring-programs/medicare-fee-service-compliance-programs/prior-authorization-pre-claim-review-initiatives/prior-authorization-certain-hospital-outpatient-department-opd-services)
17. [UnitedHealthcare Individual Exchange policy, Botulinum Toxins A and B](https://green-gateway.uhcprovider.com/content/dam/provider/docs/public/policies/exchange/botulinum-toxins-a-b-iex.pdf)
18. [AAN comment letter on proposed Botulinum Toxin Injections LCD](https://www.aan.com/siteassets/home-page/policy-and-guidelines/advocacy/comment-letters/2026/26-aan-bti-lcd-response-cgs.pdf)

WeBill Health is a specialty focused revenue cycle management partner for independent practices. Request a Revenue Defense Audit at https://webillhealth.com/form/
